Color Genomics unveils its plan to give people a peek into their genetic risk, by offering a test for hereditary cancer and high cholesterol. But, they are offering more than just that.
Genomics will change what patients expect from their provider, as well as change how physicians treat them. Before this happens, education on both sides is needed. This month we look at some of the big talking points.
Much of medicine is about information — the data that helps doctors make the right choices about our treatment. So how will the revolution in big data impact complex healthcare systems like the NHS?
Geisinger Health System CEO, Dr. David Feinberg reveals health system’s pioneering precision health efforts will be recommended to every patient.
The body is naturally geared to assimilate energy from the food we eat and store it as fat until it is needed. But now, researchers have managed to inhibit the body’s ability to store fat.
A new app helps patients with muscular dystrophy control a robotic exoskeleton that assists with everyday tasks like drinking a glass of water or turning on a light switch.
For the first time, scientists have revealed the essential genes for the most deadly human malaria parasite, Plasmodium falciparum. They have created new genomic techniques to analyse every gene in the parasite and determine which ones are indispensable.
There is concern that the White House is considering imposing further limits on research by Chinese citizens in the United States, saying that “scientific progress depends on openness, transparency, and the free flow of ideas”
Now, Salk researchers have demonstrated in mice that haemophilia B can be treated for life with one single injection, containing disease-free liver cells that can produce their missing clotting factor.
The National Insitute of Health is finally launching All of Us, a huge research study with the aim of making precision medicine available to people of all backgrounds. But will people give up their data?
Deep learning computers in a diagnostic imaging lab routinely defeat their human counterparts in diagnosing heart failure, detecting various cancers and predicting their strength.
A new method for diagnosing breast cancer involves a pill, which could do a better job distinguishing between benign and aggressive tumours.
Researchers at the Broad Institute of MIT and Harvard have reported that their platform, SHERLOCK, now can be used to detect viruses directly in clinical samples such as blood or saliva.
An FDA-approved drug originally designed to treat cancer may be an unlikely potential ally in the global fight against tuberculosis, a new study suggests.